Cargando…
Urate-Lowering Therapy May Prevent the Development of Coronary Artery Disease in Patients With Gout
Substantial evidence has demonstrated a close relationship between hyperuricemia and cardiovascular (CV) diseases, but few studies have explored the possibility of using urate-lowering therapy (ULT) to attenuate the development of CV diseases. To compare the risks of incident coronary artery disease...
Autores principales: | Yen, Fu-Shun, Hsu, Chih-Cheng, Li, Hsin-Lun, Wei, James Cheng-Chung, Hwu, Chii-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056872/ https://www.ncbi.nlm.nih.gov/pubmed/32175324 http://dx.doi.org/10.3389/fmed.2020.00063 |
Ejemplares similares
-
Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout
por: Yen, Fu-Shun, et al.
Publicado: (2020) -
Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout
por: Yen, Fu-Shun, et al.
Publicado: (2021) -
Metformin Use before Influenza Vaccination May Lower the Risks of Influenza and Related Complications
por: Yen, Fu-Shun, et al.
Publicado: (2022) -
Selection and Warning of Evidence-Based Antidiabetic Medications for Patients With Chronic Liver Disease
por: Yen, Fu-Shun, et al.
Publicado: (2022) -
Thiazolidinedione Use in Individuals With Type 2 Diabetes and Chronic Obstructive Pulmonary Disease
por: Yen, Fu-Shun, et al.
Publicado: (2021)